Related references
Note: Only part of the references are listed.Defective ALC1 nucleosome remodeling confers PARPi sensitization and synthetic lethality with HRD
Graeme Hewitt et al.
MOLECULAR CELL (2021)
Histone Parylation factor 1 contributes to the inhibition of PARP1 by cancer drugs
Johannes Rudolph et al.
NATURE COMMUNICATIONS (2021)
HPF1 and nucleosomes mediate a dramatic switch in activity of PARP1 from polymerase to hydrolase
Johannes Rudolph et al.
ELIFE (2021)
ADP-Ribosylation Levels and Patterns Correlate with Gene Expression and Clinical Outcomes in Ovarian Cancers
Lesley B. Conrad et al.
MOLECULAR CANCER THERAPEUTICS (2020)
HPF1 completes the PARP active site for DNA damage-induced ADP-ribosylation
Marcin J. Suskiewicz et al.
NATURE (2020)
Genetic screens in isogenic mammalian cell lines without single cell cloning
Peter C. DeWeirdt et al.
NATURE COMMUNICATIONS (2020)
Structural basis for allosteric PARP-1 retention on DNA breaks
Levani Zandarashvili et al.
SCIENCE (2020)
Real-time monitoring of PARP1-dependent PARylation by ATR-FTIR spectroscopy
Annika Krueger et al.
NATURE COMMUNICATIONS (2020)
Bridging of DNA breaks activates PARP2-HPF1 to modify chromatin
Silvija Bilokapic et al.
NATURE (2020)
Clinical PARP inhibitors do not abrogate PARP1 exchange at DNA damage sites in vivo
Zhengping Shao et al.
NUCLEIC ACIDS RESEARCH (2020)
Mapping Physiological ADP-Ribosylation Using Activated Ion Electron Transfer Dissociation
Sara C. Buch-Larsen et al.
CELL REPORTS (2020)
The chromatin remodeler ALC1 underlies resistance to PARP inhibitor treatment
Szilvia Juhasz et al.
SCIENCE ADVANCES (2020)
An HPF1/PARP1-Based Chemical Biology Strategy for Exploring ADP-Ribosylation
Juan Jose Bonfiglio et al.
CELL (2020)
An Advanced Strategy for Comprehensive Profiling of ADP- ribosylation Sites Using Mass Spectrometry- based Proteomics
Ivo A. Hendriks et al.
MOLECULAR & CELLULAR PROTEOMICS (2019)
PARP-1 activity (PAR) determines the sensitivity of cervical cancer to olaparib
Anna Bianchi et al.
GYNECOLOGIC ONCOLOGY (2019)
Selective Loss of PARG Restores PARylation and Counteracts PARP Inhibitor-Mediated Synthetic Lethality
Ewa Gogola et al.
CANCER CELL (2018)
Comprehensive ADP-ribosylome analysis identifies tyrosine as an ADP-ribose acceptor site
Deena M. Leslie Pedrioli et al.
EMBO REPORTS (2018)
Analysis of PARP inhibitor toxicity by multidimensional fluorescence microscopy reveals mechanisms of sensitivity and resistance
Jone Michelena et al.
NATURE COMMUNICATIONS (2018)
Serine is the major residue for ADP-ribosylation upon DNA damage
Luca Palazzo et al.
ELIFE (2018)
The comings and goings of PARP-1 in response to DNA damage
John M. Pascal
DNA REPAIR (2018)
Systems-wide Analysis of Serine ADP-Ribosylation Reveals Widespread Occurrence and Site-Specific Overlap with Phosphorylation
Sara C. Larsen et al.
CELL REPORTS (2018)
Interplay of Histone Marks with Serine ADP-Ribosylation
Edward Bartlett et al.
CELL REPORTS (2018)
Structural Basis for Potency and Promiscuity in Poly(ADP-ribose) Polymerase (PARP) and Tankyrase Inhibitors
Ann-Gerd Thorsell et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
Serine ADP-Ribosylation Depends on HPF1
Juan Jose Bonfiglio et al.
MOLECULAR CELL (2017)
The role of poly ADP-ribosylation in the first wave of DNA damage response
Chao Liu et al.
NUCLEIC ACIDS RESEARCH (2017)
Expanding functions of ADP-ribosylation in the maintenance of genome integrity
K. Martin-Hernandez et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2017)
Proteomic analyses identify ARH3 as a serine mono-ADP-ribosylhydrolase
Jeannette Abplanalp et al.
NATURE COMMUNICATIONS (2017)
Progression through mitosis promotes PARP inhibitor-induced cytotoxicity in homologous recombination-deficient cancer cells
Pepijn M. Schoonen et al.
NATURE COMMUNICATIONS (2017)
Serine ADP-ribosylation reversal by the hydrolase ARH3
Pietro Fontana et al.
ELIFE (2017)
First-in-Class Chemical Probes against Poly(ADP-ribose) Glycohydrolase (PARG) Inhibit DNA Repair with Differential Pharmacology to Olaparib
Dominic I. James et al.
ACS CHEMICAL BIOLOGY (2016)
The poly(ADP-ribose)-dependent chromatin remodeler Alc1 induces local chromatin relaxation upon DNA damage
Hafida Sellou et al.
MOLECULAR BIOLOGY OF THE CELL (2016)
HPF1/C4orf27 Is a PARP-1-Interacting Protein that Regulates PARP-1 ADP-Ribosylation Activity
Ian Gibbs-Seymour et al.
MOLECULAR CELL (2016)
Serine is a new target residue for endogenous ADP-ribosylation on histones
Orsolya Leidecker et al.
NATURE CHEMICAL BIOLOGY (2016)
Laying a trap to kill cancer cells: PARP inhibitors and their mechanisms of action
Yves Pommier et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
Mechanistic Dissection of PARP1 Trapping and the Impacton In Vivo Tolerability and Efficacy of PARP Inhibitors
Todd A. Hopkins et al.
MOLECULAR CANCER RESEARCH (2015)
The Promise of Proteomics for the Study of ADP-Ribosylation
Florian J. Bock et al.
MOLECULAR CELL (2015)
PARP-1 Activation Requires Local Unfolding of an Autoinhibitory Domain
Jennine M. Dawicki-McKenna et al.
MOLECULAR CELL (2015)
PARP-2 and PARP-3 are selectively activated by 5' phosphorylated DNA breaks through an allosteric regulatory mechanism shared with PARP-1
Marie-France aEuro Langelier et al.
NUCLEIC ACIDS RESEARCH (2014)
PARPi-FL - a Fluorescent PARP1 Inhibitor for Glioblastoma Imaging
Christopher P. Irwin et al.
NEOPLASIA (2014)
PARP Inhibitor with Selectivity Toward ADP-Ribosyltransferase ARTD3/PARP3
Anders E. G. Lindgren et al.
ACS CHEMICAL BIOLOGY (2013)
A Genetic Screen Using the PiggyBac Transposon in Haploid Cells Identifies Parp1 as a Mediator of Olaparib Toxicity
Stephen J. Pettitt et al.
PLOS ONE (2013)
Trapping of PARP1 and PARP2 by Clinical PARP Inhibitors
Junko Murai et al.
CANCER RESEARCH (2012)
Evaluation of candidate biomarkers to predict cancer cell sensitivity or resistance to PARP-1 inhibitor treatment
Lenka Oplustilova et al.
CELL CYCLE (2012)
Enhanced Killing of Cancer Cells by Poly(ADP-ribose) Polymerase Inhibitors and Topoisomerase I Inhibitors Reflects Poisoning of Both Enzymes
Anand G. Patel et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
New insights into the molecular and cellular functions of poly(ADP-ribose) and PARPs
Bryan A. Gibson et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2012)
DNA Repair Factor APLF Is a Histone Chaperone
Pawan Vinod Mehrotra et al.
MOLECULAR CELL (2011)
The structure and catalytic mechanism of a poly(ADP-ribose) glycohydrolase
Dea Slade et al.
NATURE (2011)
Integrated genomic analyses of ovarian carcinoma
D. Bell et al.
NATURE (2011)
The RIDDLE Syndrome Protein Mediates a Ubiquitin-Dependent Signaling Cascade at Sites of DNA Damage
Grant S. Stewart et al.
CELL (2009)
PARP is activated at stalled forks to mediate Mre11-dependent replication restart and recombination
Helen E. Bryant et al.
EMBO JOURNAL (2009)
Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling
Shih-Min A. Huang et al.
NATURE (2009)
Poly(ADP-ribose) polymerase 1 accelerates single-strand break repair in concert with poly(ADP-ribose) glycohydrolase
Anna E. O. Fisher et al.
MOLECULAR AND CELLULAR BIOLOGY (2007)
Radiosensitization by the poly(ADP=ribose) polymerase inhibitor 4-amino-1,8-naphthalimide is specific of the S phase of the cell cycle and involves arrest of DNA syntheses
G Noël et al.
MOLECULAR CANCER THERAPEUTICS (2006)
Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase
HE Bryant et al.
NATURE (2005)
Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy
H Farmer et al.
NATURE (2005)
Development and optimization of a binding assay for the XIAP BIR3 domain using fluorescence polarization
Z Nikolovska-Coleska et al.
ANALYTICAL BIOCHEMISTRY (2004)
BRCA2 is required for homology-directed repair of chromosomal breaks
ME Moynahan et al.
MOLECULAR CELL (2001)
Share Paper
